author-photo

Xuebing Sun

8

Papers

123

Citations

Citation Trend

Filter By

Papers (7) Sort By

Journal Conference Others

Pamiparib is a potent and selective PARP inhibitor with unique potential for the treatment of brain tumor.

2020 Neoplasia
Show All
- Source
- Cite
- Save
Citations (18)
Abstract 664: BGB-10188, a highly selective PI3Kδ inhibitor with improved safety profile and superior anti-tumor activities in vivo

2020 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)
Discovery of Pamiparib (BGB-290), a Potent and Selective Poly (ADP-ribose) Polymerase (PARP) Inhibitor in Clinical Development.

2020 Journal of Medicinal Chemistry
Show All
- Source
- Cite
- Save
Citations (6)
Abstract 3077: Preclinical characterization of BGB-11417, a potent and selective Bcl-2 inhibitor with superior antitumor activities in haematological tumor models

2020 Cancer Research
Show All
- Source
- Cite
- Save
Citations (2)
IDO1 Inhibition Synergizes with Radiation and PD-1 Blockade to Durably Increase Survival Against Advanced Glioblastoma

2018 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (85)
Abstract 1653: BGB-290: A highly potent and specific PARP1/2 inhibitor potentiates anti-tumor activity of chemotherapeutics in patient biopsy derived SCLC models

2015 Cancer Research
Show All
- Source
- Cite
- Save
Citations (10)
Studies on antiviral antibiotic 16704A.II.Antiviral activities of 16704A

2001
Show All
- Source
- Cite
- Save
Citations (0)